Abbott Laboratories (Germany) Performance
| ABL Stock | 92.77 0.82 0.89% |
The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Abbott Laboratories are expected to decrease at a much lower rate. During the bear market, Abbott Laboratories is likely to outperform the market. At this point, Abbott Laboratories has a negative expected return of -0.24%. Please make sure to confirm Abbott Laboratories' coefficient of variation, value at risk, rate of daily change, as well as the relationship between the total risk alpha and kurtosis , to decide if Abbott Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Abbott Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Forward Dividend Yield 0.0129 |
1 | Exact Sciences Stock Soars. Abbott Is Buying It for 21 Billion. - Barrons | 11/20/2025 |
2 | Abbott Laboratories ABT Shares Sold by Commonwealth Equity Services LLC - MarketBeat | 01/06/2026 |
3 | Abbott Resets Nutrition While Expanding Diagnostics And Device Growth Drivers - simplywall.st | 01/30/2026 |
| Begin Period Cash Flow | 6.9 B | |
| Free Cash Flow | 6.4 B |
Abbott |
Abbott Laboratories Relative Risk vs. Return Landscape
If you would invest 10,777 in Abbott Laboratories on November 5, 2025 and sell it today you would lose (1,500) from holding Abbott Laboratories or give up 13.92% of portfolio value over 90 days. Abbott Laboratories is generating negative expected returns and assumes 1.8759% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Abbott, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Abbott Laboratories Target Price Odds to finish over Current Price
The tendency of Abbott Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 92.77 | 90 days | 92.77 | about 98.0 |
Based on a normal probability distribution, the odds of Abbott Laboratories to move above the current price in 90 days from now is about 98.0 (This Abbott Laboratories probability density function shows the probability of Abbott Stock to fall within a particular range of prices over 90 days) .
Abbott Laboratories Price Density |
| Price |
Predictive Modules for Abbott Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Abbott Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abbott Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abbott Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Abbott Laboratories is not an exception. The market had few large corrections towards the Abbott Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Abbott Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Abbott Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.23 | |
β | Beta against Dow Jones | -0.17 | |
σ | Overall volatility | 5.90 | |
Ir | Information ratio | -0.15 |
Abbott Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Abbott Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Abbott Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Abbott Laboratories generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Abbott Resets Nutrition While Expanding Diagnostics And Device Growth Drivers - simplywall.st |
Abbott Laboratories Fundamentals Growth
Abbott Stock prices reflect investors' perceptions of the future prospects and financial health of Abbott Laboratories, and Abbott Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abbott Stock performance.
| Current Valuation | 163.2 B | |||
| Price To Book | 3.75 X | |||
| Price To Sales | 4.34 X | |||
| Revenue | 41.95 B | |||
| EBITDA | 10.69 B | |||
| Net Income | 13.4 B | |||
| Total Debt | 1.5 B | |||
| Cash Flow From Operations | 8.56 B | |||
| Total Asset | 81.41 B | |||
| Retained Earnings | 47.26 B | |||
About Abbott Laboratories Performance
Assessing Abbott Laboratories' fundamental ratios provides investors with valuable insights into Abbott Laboratories' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Abbott Laboratories is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Abbott Laboratories is entity of Germany. It is traded as Stock on STU exchange.Things to note about Abbott Laboratories performance evaluation
Checking the ongoing alerts about Abbott Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abbott Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abbott Laboratories generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Abbott Resets Nutrition While Expanding Diagnostics And Device Growth Drivers - simplywall.st |
- Analyzing Abbott Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abbott Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Abbott Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abbott Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abbott Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abbott Laboratories' stock. These opinions can provide insight into Abbott Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.